Experimental evidence indicates that the interaction between ALMS1‐IT1 and AVL9 may contribute to the malignant advancement of Lung Adenocarcinoma (LUAD) by influencing the cyclin‐dependent kinase pathway.27 The gene discussed is ALMS1; the disease is lung adenocarcinoma.